logo

For the Inventor, By the Inventor

Amsterdam, Netherlands

Antony M Akkerman

This inventor holds 7 USPTO granted patents. Top assignee: Acf Chemiefarma N.v.. Active years: 1977-1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antony M Akkerman. Retrieved from https://idiyas.com/inventor/antony-m-akkerman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 45(Granted Patents)


Company Filing History:

goldMedal7 out of 16 
 
Acf Chemiefarma N.v.
 patents

Years Active: 1977-1984

Loading Chart...
7 patents (USPTO):Explore Patents
1. 4473576 - Analgesic 9,9-dimethylbenzomorphanes (1984-09-25),
2. 4425353 - Analgesic 5-oxygenated-6,7-benzomorphan derivatives (1984-01-10),
3. 4288444 - Analgesic and morphine-antagonistic 6,7-benzomorphans (1981-09-08),
4. 4268673 - 5-Unsubstituted-9,9-dimethyl-6,7-benzomorphans (1981-05-19),
5. 4234591 - Analgesic and morphine-antagonistic 9-phenyl-6,7-benzomorphans (1980-11-18),
6. 4128548 - Process for preparing 6,7-benzomorphans (1978-12-05),
7. 4012392 - 2-Benzyl-4-piperidones useful as intermediates in the production of (1977-03-15),

Title: **Inventor Spotlight: Antony M Akkerman**

Introduction

Antony M Akkerman is a prominent inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of pharmacology with a total of 7 patents to his name. His work primarily revolves around analgesic compounds, showcasing his innovation in developing new drugs with therapeutic properties.

Latest Patents

Akkerman's latest patents focus on a range of benzomorphan derivatives. Notably, he developed the patent for "Analgesic 9,9-dimethylbenzomorphanes," which includes compounds that possess analgesic and morphine-antagonist properties. Additionally, he holds a patent for "Analgesic 5-oxygenated-6,7-benzomorphan derivatives." This patent features derivatives with multiple potential substitutions that also exhibit analgesic effects and can inhibit luteinizing hormone secretion, highlighting his innovative approach to drug development.

Career Highlights

Antony M Akkerman is affiliated with ACF Chemiefarma N.V., where he has been instrumental in advancing the company's research and development in pharmaceutical innovations. His dedication to discovering new compounds and their therapeutic effects underscores his commitment to improving medical science and patient care.

Collaborations

Throughout his career, Akkerman has collaborated with esteemed colleagues, including Hermanus C Van Bakel and Geertruida C Van Leeuwen. Their collective expertise contributes to the success of their research endeavors and enhances the impact of their innovative solutions in the pharmaceutical industry.

Conclusion

Antony M Akkerman stands out as a significant figure in the realm of medicinal inventions. With his inventive spirit and unwavering commitment to advancing pharmacological sciences, his work is poised to make lasting contributions to pain management and therapeutic advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…